Anticoagulation Beyond 3 to 6Months: What Does the Data Tell Us?
Sign Up to like & getrecommendations! Published in 2018 at "Progress in cardiovascular diseases"
DOI: 10.1016/j.pcad.2018.04.002
Abstract: Patients with a history of deep vein thrombosis and pulmonary embolism are at risk for a recurrent event. This is particularly true of patients with idiopathic events or events related to low risk triggers. In… read more here.
Keywords: risk; 6months data; beyond 6months; data tell ... See more keywords
Tinzaparin in cancer associated thrombosis beyond 6months: TiCAT study.
Sign Up to like & getrecommendations! Published in 2017 at "Thrombosis research"
DOI: 10.1016/j.thromres.2017.07.004
Abstract: INTRODUCTION The safety and efficacy of low-molecular-weight heparin (LMWH) treatment in patients with cancer-associated thrombosis (CAT) beyond 6months are unknown. Our aim was to determine the safety of long-term tinzaparin use in patients with CAT.… read more here.
Keywords: tinzaparin; beyond 6months; clinically relevant; cancer associated ... See more keywords